A phase I trial of AF 219.

Trial Profile

A phase I trial of AF 219.

Phase of Trial: Phase I

Latest Information Update: 23 Dec 2009

At a glance

  • Drugs Gefapixant (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Afferent Pharmaceuticals
  • Most Recent Events

    • 23 Dec 2009 New trial record
    • 17 Dec 2009 According to an Afferent Pharmaceuticals media release this phase I trial of AF 219 is complete.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top